Literature DB >> 15208323

The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK.

Renae K Barr1, Ingrid Boehm, Paul V Attwood, Paul M Watt, Marie A Bogoyevitch.   

Abstract

We previously reported that a small peptide based on amino acids 143-153 of the c-Jun N-terminal kinase (JNK)-binding domain of JIP-1 functioned as an in vitro inhibitor of JNK activity. This peptide (TI-JIP: RP-KRPTTLNLF) resembles the kinase-interaction motif (KIM = (K/R)(2-3)X(1-6)(L/I)X(L/I)), which is common to upstream activators, downstream substrates, phosphatases, and scaffold proteins present in MAPK cascades. In this study, we characterized the mechanism of JNK inhibition by this peptide and further investigated the biochemical features of this peptide resulting in potent JNK inhibition. We also tested various KIM-based peptides for their ability to inhibit JNK activity. TI-JIP was found to be competitive with respect to the phosphoacceptor substrate c-Jun (K(I) = 0.39 +/- 0.08 microm), and exhibit mixed (non-competitive) inhibition with respect to ATP. All seven substitutions of Pro-5 we tested significantly reduced the JNK inhibition, as did altering the Pro-5 to Leu-8 spacing. When we independently tested eight substitutions of either Thr-6 or Thr-7, only one substitution in each position was well tolerated. Furthermore, peptides based on the KIMs from other proteins were significantly less potent JNK inhibitors than TI-JIP, including a peptide from the JNK interactor Sab that contained all critical inhibitory residues present in TI-JIP. Therefore, despite having previously identified Arg-4, Pro-5, Leu-8, and Leu-10 in TI-JIP as independently critical for mediating JNK inhibition, we find their presence in other 11-mer peptides is not sufficient for JNK inhibition. TI-JIP is therefore a unique KIM-based inhibitor of JNK activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208323     DOI: 10.1074/jbc.M402181200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

Review 2.  Analysis of mitogen-activated protein kinase activation and interactions with regulators and substrates.

Authors:  Lee Bardwell; Kandarp Shah
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

4.  Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensor.

Authors:  Matthew Fosbrink; Nwe-Nwe Aye-Han; Raymond Cheong; Andre Levchenko; Jin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

5.  Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1).

Authors:  Jeremy W Chambers; Lisa Cherry; John D Laughlin; Mariana Figuera-Losada; Philip V Lograsso
Journal:  ACS Chem Biol       Date:  2011-05-24       Impact factor: 5.100

6.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.

Authors:  Jeffrey J Babon; Nadia J Kershaw; James M Murphy; Leila N Varghese; Artem Laktyushin; Samuel N Young; Isabelle S Lucet; Raymond S Norton; Nicos A Nicola
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

Review 7.  Mitogen activated protein kinase inhibitors: where are we now and where are we going?

Authors:  S E Sweeney; G S Firestein
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

8.  Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration.

Authors:  Tamer S Kaoud; Shreya Mitra; Sunbae Lee; Juliana Taliaferro; Michael Cantrell; Klaus D Linse; Carla L Van Den Berg; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2011-04-05       Impact factor: 5.100

9.  A small molecule bidentate-binding dual inhibitor probe of the LRRK2 and JNK kinases.

Authors:  Yangbo Feng; Jeremy W Chambers; Sarah Iqbal; Marcel Koenig; HaJeung Park; Lisa Cherry; Pamela Hernandez; Mariana Figuera-Losada; Philip V LoGrasso
Journal:  ACS Chem Biol       Date:  2013-06-10       Impact factor: 5.100

10.  Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo.

Authors:  Jeremy W Chambers; Shannon Howard; Philip V LoGrasso
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.